ALT vs. METCB
Compare and contrast key facts about Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALT or METCB.
Key characteristics
| ALT | METCB | |
|---|---|---|
| YTD Return | -43.20% | -12.84% |
| 1Y Return | 156.63% | 5.78% |
| Sharpe Ratio | 1.42 | 0.08 |
| Daily Std Dev | 109.06% | 52.48% |
| Max Drawdown | -99.94% | -35.93% |
| Current Drawdown | -99.76% | -28.74% |
Fundamentals
| ALT | METCB | |
|---|---|---|
| Market Cap | $461.96M | $573.60M |
| EPS | -$1.63 | $1.08 |
| Total Revenue (TTM) | $409.00K | $717.69M |
| Gross Profit (TTM) | -$20.04M | $154.93M |
| EBITDA (TTM) | -$95.23M | $152.60M |
Correlation
The correlation between ALT and METCB is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ALT vs. METCB - Performance Comparison
In the year-to-date period, ALT achieves a -43.20% return, which is significantly lower than METCB's -12.84% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALT vs. METCB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ALT vs. METCB - Dividend Comparison
ALT has not paid dividends to shareholders, while METCB's dividend yield for the trailing twelve months is around 8.73%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
ALT Altimmune, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.87% |
METCB Ramaco Resources Inc. | 8.73% | 3.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ALT vs. METCB - Drawdown Comparison
The maximum ALT drawdown since its inception was -99.94%, which is greater than METCB's maximum drawdown of -35.93%. Use the drawdown chart below to compare losses from any high point for ALT and METCB. For additional features, visit the drawdowns tool.
Volatility
ALT vs. METCB - Volatility Comparison
Altimmune, Inc. (ALT) has a higher volatility of 25.33% compared to Ramaco Resources Inc. (METCB) at 9.91%. This indicates that ALT's price experiences larger fluctuations and is considered to be riskier than METCB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ALT vs. METCB - Financials Comparison
This section allows you to compare key financial metrics between Altimmune, Inc. and Ramaco Resources Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities